Breast Cancer Perspective

• When to Screen BRCA Carriers for Colorectal, Pancreatic Cancer   New guidelines illuminate how these mutations can increase risk, but the final decision requires our own judgment, according to Dr David Johnson.
  Medscape Gastroenterology, August 10, 2020
• Treating Breast Cancer During COVID-19: 'Indispensable' In the midst of a pandemic, how can oncologists best continue therapy for their patients with breast cancer? The experts define treatment protocols and priorities.
  Medscape Oncology, August 06, 2020
• Two Decades in Oncology Don't Afford You Immunity to Grief In this moving essay, oncologist Don Dizon reflects on the loss of a close family member to cancer.
  Medscape Oncology, July 31, 2020
• Time to Stop Pressuring Women on Screening Mammography?   New research suggests that screening mammography might not be the key to lower breast cancer mortality.
  Medscape Ob/Gyn, July 30, 2020
• The Oncologist's Role With Savvy Patients   Patients are savvy, says Dr Mark Lewis. Oncologists are uniquely positioned to help patients navigate the labyrinth of novel therapies and determine the best treatment options.
  Medscape Oncology, July 21, 2020
• Treating Colorectal Cancer in the COVID-19 Era Drs David Kerr and David Henry discuss the data behind Kerr's recent recommendations on what adjustments may be necessary during the pandemic.
  Medscape Oncology, July 21, 2020
• New MBC Treatments: Triple-Negative; HER2+; and ER+, HER2- The latest therapeutic options improve progression-free survival for some patients.
  Medscape Oncology, July 16, 2020
• Surprising Results From the PALLAS Trial   Dr Kathy Miller discusses the surprising -- and disappointing -- results from the PALLAS trial, which caught many off-guard by being announced via press release after the virtual ASCO meeting.
  Medscape Oncology, July 01, 2020
• Progress in Targeted Therapy for Lung Cancer: New Data   Dr Mark Kris explains why he is even more hopeful when it comes to targeted therapy for lung cancer after seeing several trial results presented during this year's virtual ASCO meeting.
  Medscape Oncology, June 30, 2020
• Should ADAURA Trial Results Change Practice in NSCLC?   Dr Mark Kris says yes and explains why he thinks 3-year treatment with osimertinib should become the new standard of care for patients with EGFR mutation–positive NSCLC.
  Medscape Oncology, June 30, 2020
• Early Breast Cancer Highlights From ASCO 2020   Early breast cancer highlights from ASCO 2020 include refinement of adjuvant regimens in HER2+, selection of patients for chemo in ER+, and large-dose capecitabine maintenance in operable TNBC.
  Medscape, June 24, 2020
• Key Studies in Metastatic Breast Cancer From ASCO 2020   Key studies in metastatic breast cancer from ASCO 2020 focus on first-line checkpoint inhibition in TNBC; also, updated evidence that tucatinib plus chemotherapy benefits women with HER2+ disease.
  Medscape, June 23, 2020
• In Breast Cancer, Is Chemobrain Really 'Endocrine Brain'?   Dr Kathy Miller explores how new data from the TAILORx trial change our understanding of a common but -- to date -- poorly defined side effect.
  Medscape Oncology, June 22, 2020
• Metastatic Breast Cancer Symptom Management: 5 Things to Know By addressing MBC patients' perspectives on meaningful symptom improvement and priorities for symptom management, oncologists can ensure treatment is consistent with patient values and goals.
  Medscape Oncology, June 18, 2020
• Three Practice-Informing Breast Cancer Trials From ASCO 2020   Dr Kathy Miller comments on three breast cancer trials presented at this year's virtual ASCO meeting and notes that even a negative trial can have a silver lining.
  Medscape Oncology, June 18, 2020
• Practice-Changing GI Cancer Highlights From Virtual ASCO 2020   Gastrointestinal cancer expert Dr John Marshall gives his high-level overview of the most important developments in GI cancers, presented at the recent virtual ASCO 2020 meeting.
  Medscape Oncology, June 12, 2020
• COVID-19 Diary Week 5: We're Open, but Where Are All the Patients? Hospitals and cancer centers are opening back up, but patients who have suffered the 'societal trauma' of COVID-19 are not coming in.
  Medscape Oncology, May 29, 2020
• ASCO Plenary Highlights Importance of Publicly Funded Research The question posited by the E2108 study, which is being presented at this year's ASCO annual meeting, may not have a financial incentive, but it is vital for clinical practice.
  Medscape Oncology, May 29, 2020
• How a Small Oncology Practice Has Adapted to COVID-19 Drs David Henry and Matthew Lonergan, from different practices on opposite sides of the country, discover many similarities in how COVID-19 is changing daily life for providers and patients.
  Medscape Oncology, May 28, 2020
• Positive Strides in Triple-Negative Breast Cancer: Increased Options for Advanced Disease   Experts report on developments that could extend progression-free survival and improve quality of life for women with metastatic triple-negative breast cancer.
  Medscape TV, May 27, 2020